| Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in Candida albicans Strains Displaying High-Level Fluconazole Resistance Isolated … S Perea, JL López-Ribot, WR Kirkpatrick, RK McAtee, RA Santillán, ... Antimicrobial agents and chemotherapy 45 (10), 2676-2684, 2001 | 630 | 2001 |
| Antifungal resistance in pathogenic fungi GM Eliopoulos, S Perea, TF Patterson Clinical Infectious Diseases 35 (9), 1073-1080, 2002 | 443 | 2002 |
| Efficacy of caspofungin alone and in combination with voriconazole in a guinea pig model of invasive aspergillosis WR Kirkpatrick, S Perea, BJ Coco, TF Patterson Antimicrobial agents and chemotherapy 46 (8), 2564-2568, 2002 | 348 | 2002 |
| Prevalence and risk factors of tinea unguium and tinea pedis in the general population in Spain S Perea, MJ Ramos, M Garau, A Gonzalez, AR Noriega, A del Palacio Journal of clinical microbiology 38 (9), 3226-3230, 2000 | 314 | 2000 |
| An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors ML Amador, D Oppenheimer, S Perea, A Maitra, G Cusati, ... Cancer Research 64 (24), 9139-9143, 2004 | 310 | 2004 |
| In Vitro Interaction of Caspofungin Acetate with Voriconazole against Clinical Isolates of Aspergillus spp S Perea, G Gonzalez, AW Fothergill, WR Kirkpatrick, MG Rinaldi, ... Antimicrobial agents and chemotherapy 46 (9), 3039-3041, 2002 | 235 | 2002 |
| Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial M Hidalgo, J Hornedo, C Lumbreras, JM Trigo, R Colomer, S Perea, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 1999 | 151 | 1999 |
| Multiple Resistant Phenotypes of Candida albicansCoexist during Episodes of Oropharyngeal Candidiasis in Human Immunodeficiency Virus-Infected Patients JL Lopez-Ribot, RK McAtee, S Perea, WR Kirkpatrick, MG Rinaldi, ... Antimicrobial agents and chemotherapy 43 (7), 1621-1630, 1999 | 140 | 1999 |
| Comparison of high-performance liquid chromatographic and microbiological methods for determination of voriconazole levels in plasma S Perea, GJ Pennick, A Modak, AW Fothergill, DA Sutton, DJ Sheehan, ... Antimicrobial agents and chemotherapy 44 (5), 1209-1213, 2000 | 130 | 2000 |
| Comparison of in vitro activities of voriconazole and five established antifungal agents against different species of dermatophytes using a broth macrodilution method S Perea, AW Fothergill, DA Sutton, MG Rinaldi Journal of clinical Microbiology 39 (1), 385-388, 2001 | 121 | 2001 |
| Spread of Amikacin Resistance inAcinetobacter baumannii Strains Isolated in Spain Due to an Epidemic Strain J Vila, J Ruiz, M Navia, B Becerril, I Garcia, S Perea, I Lopez-Hernandez, ... Journal of clinical microbiology 37 (3), 758-761, 1999 | 118 | 1999 |
| Molecular Mechanisms of Fluconazole Resistance in Candida dubliniensis Isolates from Human Immunodeficiency Virus-Infected Patients with Oropharyngeal … S Perea, JL López-Ribot, BL Wickes, WR Kirkpatrick, OP Dib, ... Antimicrobial agents and chemotherapy 46 (6), 1695-1703, 2002 | 108 | 2002 |
| In Vitro Activities of Terbinafine in Combination with Fluconazole, Itraconazole, Voriconazole, and Posaconazole against Clinical Isolates of Candida glabrata with … S Perea, G Gonzalez, AW Fothergill, DA Sutton, MG Rinaldi Journal of clinical microbiology 40 (5), 1831-1833, 2002 | 88 | 2002 |
| Phase I/II trial to evaluate the efficacy and safety of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with pancreatic cancer and an ECOG … T Macarulla, R Pazo-Cid, C Guillén-Ponce, R López, R Vera, M Reboredo, ... Journal of Clinical Oncology 37 (3), 230-238, 2019 | 81 | 2019 |
| PDX-derived organoids model in vivo drug response and secrete biomarkers L Huang, B Bockorny, I Paul, D Akshinthala, PO Frappart, O Gandarilla, ... JCI insight 5 (21), 2020 | 76 | 2020 |
| Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for … M Martinez, JL Lopez-Ribot, WR Kirkpatrick, SP Bachmann, S Perea, ... Journal of Antimicrobial Chemotherapy 49 (3), 515-524, 2002 | 74 | 2002 |
| Integron-mediated antibiotic multiresistance in Acinetobacter baumannii clinical isolates from Spain J Ruiz, MM Navia, C Casals, JM Sierra, MTJ De Anta, J Vila Clinical microbiology and infection 9 (9), 907-911, 2003 | 62 | 2003 |
| Invasive Aspergillus infections in hematologic malignancy patients. S Perea, TF Patterson Seminars in respiratory infections 17 (2), 99-105, 2002 | 60 | 2002 |
| Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab RA Toledo, A Cubillo, E Vega, E Garralda, R Alvarez, LU de la Varga, ... Oncotarget 8 (21), 35289, 2017 | 59 | 2017 |
| OMTX705, a novel FAP-targeting ADC demonstrates activity in chemotherapy and pembrolizumab-resistant solid tumor models M Fabre, C Ferrer, S Domínguez-Hormaetxe, B Bockorny, L Murias, ... Clinical Cancer Research 26 (13), 3420-3430, 2020 | 53 | 2020 |
